abc biopply
Allschwil, Switzerlandbiopply.comFrom their website, Nov 2026
Work here? Claim this listing
About
abc biopply AG provides preclinical CRO services and assay licensing based on proprietary 3D CoSeedis humanized multi-organoid in-chip technology. It works with biotech and pharma clients on drug efficacy, safety, toxicity, resistance, biomarker development, and custom disease-model design from its sites in Allschwil, Basel and Solothurn, Switzerland.
Services
Preclinical CRO Services
Validated preclinical services for drug efficacy, safety, toxicity, resistance, and biomarker development on clinically relevant multi-organoid disease models.
Service Packages
Bundled assay sets for drug development questions such as efficacy, resistance, toxicity, safety, target validation, marker studies, omics, and study planning.
Assays
Highly standardized and validated 3D CoSeedis in-chip assays for individual preclinical readouts and project-specific study needs.
Licenses
In-licensing options for the company's assays, protocols, disease models, and technology for in-house use.
Custom-tailored model development
Design and development of custom disease models, including characterization and biomarker discovery.
Integrated preclinical services
Preclinical services that combine in vitro to in vivo work synchronized with humanized mouse models through partner laboratories.
Target validation package
Package for target localization, binding, activation, tissue penetration, and cytotoxicity studies during drug development and optimization.
Rapid Drug Efficacy Check
Package for rapid prediction of clinically relevant drug efficacy and dosage using 3D CoSeedis tumor models and dose-response readouts.
11 more services
- Drug Safety Package
- Drug Resistance Check
- Personalized Efficacy Package
- Personalized Toxicity Target and off-Target Package
- Pathway Analysis Package
- Drug Response Package
- Cell Viability Package
- Organoid service packages
- Licensing of assays and protocols
- Custom disease model development
- Integrated preclinical study support
- Turnaround
- 10 weeks to result
- 12 weeks to result
- What to send
- Choose a 3D CoSeedis tumor model
- One drug - one target
Capabilities
- Assays and studies
- Toxicology
- In vivo
- Rodent models
- Apoptosis
- Co-culture
- Cytotoxicity
17 more
- Dose response
- Drug efficacy
- Tumor relapse
- Histology
- Live cell detection
- Antibody penetration
- Late stage cancer relapse
- Colony forming
- Off-target cytotoxicity
- Drug penetration
- Marker studies
- Omics
- IC50 determination
- Drug efficacy assay
- Drug safety assay
- Toxicology assay
- Drug resistance assay
- Scale and capacity
- Up to 1000 replicates
- Therapeutic areas
- Oncology
- Neurology
- Hepatology
- Nephrology
- Obesity
- Cartilage
- Renal
Instruments and platforms
- 3D CoSeedis in chip technology
- 3D CoSeedis™ chips
Modalities and species
- Modalities
- Organoid models
- Multi-organoid disease models
- Humanized mouse models
- Patient-derived cells
- Organoid
- Humanized multi-organoid disease models
- Species and models
- 3D CoSeedis tumor models
- Oncology
- Neurology
- Hepatic
- Renal
- Cartilage
6 more
- Obesity
- PDCs
- Humanized mouse models
- Patient tissues
- Healthy tissues
- Diseased tissues
Industries served
- Biotech
- Pharma
Details
- Type
- CRO
- Founded
- 2018
- Address
- Hegenheimermattweg 167A, 4123 Allschwil, Switzerland
- Sites
- Allschwil, Basel, Switzerland · Solothurn, Switzerland
- Serves
- Switzerland, EU, Canada, international, CH